Three Samsung biotech companies form business partnership with Moderna parent company in the US = South Korean report

Samsung C&T and its subsidiaries, Samsung Biologics and Samsung Bioepis, are working with a U.S. venture investment company in the "Life Science Fund No. 2" formed by the three companies.